Community perspectives on self- testing for HIV and HCV in the WHO European region

European Meeting on HIV & Hepatitis 2022

Viral load suppression after three-year Ibalizumab treatment in a multidrug-resistant HIV-1- infected woman: Clinical experience.

European Meeting on HIV & Hepatitis 2022

CASE - HIV+ End-Stage Renal Disease Patient with Immunosuppressive Drug-Drug Interactions Received Successful Transplantation after Ibalizumab Suppressed Switch

European Meeting on HIV & Hepatitis 2022

Clinical course of AIDS with COVID-19 coinfection with prolonged SARS CoV-2 replication despite remdesivir/molnupiravir treatment.

European Meeting on HIV & Hepatitis 2022

A Case of IRIS Syphilis Due to Prozone Effect

European Meeting on HIV & Hepatitis 2022

Conference on Liver Disease in Africa (COLDA) 2021

International Workshop on Clinical Pharmacology of HIV, Hepatitis and Other Antiviral Drugs 2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

International Viral Hepatitis Elimination Meeting (IVHEM) 2021

International Viral Hepatitis Elimination Meeting (IVHEM) 2022

International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2022

SARS-CoV-2 antibody seroprevalence in previously undiagnosed persons in Tbilisi, Georgia: Results of three repeated serosurveys

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Rate of HCV reinfection among people living with HCV following successful DAA therapy in Tbilisi, Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

COVID-19 Challenges and Scale-up in Access to Community-based HCV Treatment for HIV/HCV Co-infected PWIDs in Ukraine

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Dynamics and peculiarities of AIDS mortality in Minsk, Belarus

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

“Evaluate potential impact of COVID-19 pandemic on HIV testing and care national program in the republic of Georgia”

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Effect of remdesivir on mortality in patients with COVID-19: A retrospective cohort study

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Integrating viral hepatitis and PrEP services through KP-led clinics in Vietnam: An opportunity to achieve dual elimination of HIV and viral hepatitis by 2030

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Prevalence of undiagnosed HBV infection in patients with COVID-19

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Obstetric complications in HIV-positive pregnant women, depending on the level of HIV RNA and CD4 count

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Post-discharge mortality among hospitalized HIV positive persons

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Outcomes of HIV pre-exposure prophylaxis (PrEP) program in Georgia for the reporting period from October 2017 to June 2021

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Surveillance of SARS-CoV-2 among employees of front-line healthcare facility in Tbilisi Georgia

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021

Incidence and residual risk of HCV in Lithuanian blood donors from 2004 to 2018: call for screening improvement in a general population

Central and Eastern European Meeting on Viral Hepatitis and HIV 2021